T863
SIGMA/SML0539 - ≥98% (HPLC)
Synonym: 2-
CAS Number: 701232-20-4
Empirical Formula (Hill Notation): C22H26N4O3
Molecular Weight: 394.47
MDL Number: MFCD11977270
Linear Formula: C22H26N4O3
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C22H26N4O3/c1-22(2)19( |
| InChI key | FUIYMYNYUHVDPT-HDJSIYSDSA |
| Quality Level | 100 ![]() |
| SMILES string | CC1(C)Oc2ncnc(N)c2N=C1c3c |
| solubility | DMSO: 15 mg/mL (clear solution) |
| storage temp. | 2-8°C |
| Application: | T863 has been used as a diglyceride acyltransferase (DGAT1) inhibitor: • to provide the opportunity to precisely control the DGAT inhibition • to treat mouse embryonic fibroblasts (MEFs) to analyse lipid droplet biogenesis • to specifically block neutral lipid synthesis and lipid droplet formation in HT-1080 cells • to block lipid droplet (LD) formation |
| Biochem/physiol Actions: | T863 is an orally active, selective and potent DGAT1 (Acyl-CoA:diacylglycerol acyltransferase 1) inhibitor that interacts with the acyl-CoA binding site of DGAT1, and inhibits triacylglycerol synthesis in cells. T863 causes weight loss, reduction in serum and liver triglycerides, and improved insulin sensitivity in obese mice. |
| Biochem/physiol Actions: | T863 is an orally active, selective and potent DGAT1 inhibitor. |
| Packaging: | 5, 25 mg in glass bottle |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 51111800 |

